T Cell immune reconstitution after allo-HSCT: key factors and implications
Open Access
- 1 December 2025
- journal article
- Published by Wolters Kluwer Health in Blood Science
- Vol. 7 (4) , e00261
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents a curative therapy for hematological malignancies, with T-cell immune reconstitution playing a pivotal role in determining clinical outcomes. This review comprehensively illustrates the processes and influencing factors of T-cell recovery post-HSCT, highlighting the dual pathways of reconstitution: thymus-independent peripheral expansion and thymus-dependent central regeneration. Key factors such as recipient and donor age, human leukocyte antigen disparity, conditioning regimens, immunosuppressive therapies, cytomegalovirus reactivation, and graft-versus-host disease (GVHD) significantly impact T-cell reconstitution dynamics and functional recovery. Furthermore, the article discusses the critical balance between graft-versus-leukemia (GVL) effects and GVHD, emphasizing how T-cell exhaustion, inhibitory receptor overexpression, and clonal dynamics contribute to relapse. Emerging technologies, including single-cell multi-omics, spatially resolved proteomics, T cell receptor repertoire analysis, and artificial intelligence-driven modeling, are explored for their potential to deepen mechanistic understanding and enable personalized therapeutic strategies. Ultimately, enhancing T-cell reconstitution through optimized transplantation protocols and targeted interventions is essential for reducing complications and improving long-term survival.Keywords
This publication has 81 references indexed in Scilit:
- In Vitro Effects of Cyclosporine A and Tacrolimus on Regulatory T-Cell Proliferation and FunctionTransplantation, 2012
- Immune Reconstitution Following Unmanipulated HLA-Mismatched/Haploidentical Transplantation Compared with HLA-Identical Sibling TransplantationJournal of Clinical Immunology, 2011
- Thymic T-cell development in allogeneic stem cell transplantationBlood, 2011
- Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in HumansScience, 2010
- Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2008
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignanciesBone Marrow Transplantation, 2006
- Role for granulocyte colony–stimulating factor in the generation of human T regulatory type 1 cellsBlood, 2002
- Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitutionThe Lancet, 2000
- Changes in thymic function with age and during the treatment of HIV infectionNature, 1998